Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Warby Parker is valued at $1.75 billion after a pre-IPO investment of $75 million

The company has now raised nearly $300 million in total.

Warby Parker Co-CEOs Neil Blumenthal and Dave Gilboa wear medals for the 2017 Jefferson Award for Outstanding Service by a Company during the Jefferson Awards Foundation 2017 NYC National Ceremony
Warby Parker Co-CEOs Neil Blumenthal and Dave Gilboa wear medals for the 2017 Jefferson Award for Outstanding Service by a Company during the Jefferson Awards Foundation 2017 NYC National Ceremony
Warby Parker Co-CEOs Neil Blumenthal and Dave Gilboa wear medals for the 2017 Jefferson Award for Outstanding Service by a Company
Bryan Bedder/Getty Images for Jefferson Awards Foundation
Jason Del Rey
Jason Del Rey has been a business journalist for 15 years and has covered Amazon, Walmart, and the e-commerce industry for the last decade. He was a senior correspondent at Vox.

Warby Parker’s co-CEOs continue to talk about an IPO like it’s a “when,” not an “if.” But the “when” still isn’t now.

The eight-year-old eyewear retailer announced a new investment of $75 million on Wednesday led by its existing backer T. Rowe Price that will keep it a private company for at least the near future.

The new funding values the New York City-based company at $1.75 billion, according to a person familiar with its finances, and is expected to help it fuel several new initiatives before having to prove its payoff to public-market investors. Warby Parker last raised a $100 million investment about three years ago that valued the company at $1.2 billion, and has now raised nearly $300 million in total.

“Given the rationale for raising this capital is to invest in future products and services, sometimes those investments are easier to make as a private company,” Warby Parker co-founder and co-CEO Dave Gilboa told Recode in an interview. “And hopefully by the time that we do go public, we’ve proven kind of the value to the business of some of them.”

One of those initiatives, Gilboa said, is the company’s Prescription Check mobile app, which lets eligible customers acquire a new prescription without having to visit an eye doctor in person.

Warby Parker was founded in 2010 and quickly gained popularity for its $95 on-trend prescription eyeglasses that could be ordered online and tried on at home. The company has since opened 65 brick-and-mortar retail shops to complement its online business, and expects to close 2018 with nearly 100 retail locations.

Warby Parker doesn’t disclose its revenue — nor even a year-over-year growth rate metric favored by startups that want to come across as transparent even when they’re not — but says it will be profitable on an Ebitda basis this year for the first time.

Gilboa attributed the profitability breakthrough to accelerating revenue growth, supply chain improvements and the opening of the company’s new Optical Lab, which pulls more assembly work in-house while boosting gross margins.

Warby Parker also recently added its first woman to the board of directors: Youngme Moon, a well-respected Harvard Business School professor who already serves on the boards of Unilever, Japanese e-commerce giant Rakuten and fast-growing salad chain Sweetgreen. The other seven board members, all men, include Warby’s four co-founders, two investors, and former J.Crew and Gap CEO Mickey Drexler.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh